$VICR

VINCIARELLI PATRIZIO sold $435K of VICR

VINCIARELLI PATRIZIO (Chairman and CEO) sold 1,336 shares of VICOR CORP (VICR) at $325.44 ($0.43M total) on 2026-06-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · VINCIARELLI PATRIZIO
Published Jun 3, 2026, 3:31 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 3, 2026, 3:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

The filing updates the public record of insider activity (sale size, price, and post-transaction holdings) but does not introduce new operating or financial information.

02

Market read

A single insider sale under 10b5-1 is typically a low-signal event; any trading effect is likely short-lived sentiment noise.

03

What to watch

Traders may overreact to insider sales; the key is whether there are concurrent buys/sales patterns or changes in trading plans not shown here.

Relevance 6/10Novelty 3/10Timing: Filed today; sale executed 2026-06-02.

Background

This is an SEC Form 4 insider transaction (officer/director/10% owner) for Vicor Corp, disclosed after execution.

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

Vinciarelli (Chairman/CEO/10% owner) filed an open-market sale of 1,336 shares at ~$325.44 on 2026-06-02 under a 10b5-1 plan.

Expected impact

Near-term impact likely muted; any reaction would be sentiment-driven rather than fundamentals.

Evidence & confidence

Form 4 provides a discrete datapoint (sale size/price) but explicitly notes a pre-arranged 10b5-1 plan, reducing interpretability as a new bearish thesis.

Market effects

No sector-wide implications; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect routine liquidity rather than negative expectations.

Key entities

  • VICOR CORP

    Subject of the Form 4 insider sale disclosure.

  • VINCIARELLI PATRIZIO

    Chairman and CEO; executed an open-market sale under a 10b5-1 plan.

Related articles

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: